Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Haematologica|November 25, 2017
Clustered <i>F8</i> missense mutations cause hemophilia A by combined alteration of splicing and protein biosynthesis and activityIrving Donadon, John H McVey, Isabella Garagiola, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 19, 2022
Genetic variants at the chromosomal region 2q21.3 underlying inhibitor development in patients with severe haemophilia ASilvia Spena, Andrea Cairo, Emanuela Pappalardo, et al.
European Journal of Human Genetics : EJHG|October 21, 2020
X Chromosome inactivation: a modifier of factor VIII and IX plasma levels and bleeding phenotype in Haemophilia carriersIsabella Garagiola, Mimosa Mortarino, Simona Maria Siboni, et al.
Haematologica|January 1, 2009
The first deletion mutation in the TSP1-6 repeat domain of ADAMTS13 in a family with inherited thrombotic thrombocytopenic purpuraRoberta Palla, Silvia Lavoretano, Rossana Lombardi, et al.
Pharmaceuticals (Basel, Switzerland)|October 27, 2022
Updates on Novel Non-Replacement Drugs for HemophiliaRoberta Gualtierotti, Samantha Pasca, Alessandro Ciavarella, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Molecular Aggregation of Marketed Recombinant FVIII Products: Biochemical Evidence and Functional EffectsRaimondo De Cristofaro, Monica Sacco, Stefano Lancellotti, et al.
Blood|April 10, 2016
Whole-exome sequencing to identify genetic risk variants underlying inhibitor development in severe hemophilia A patientsMarcin M Gorski, Kevin Blighe, Luca A Lotta, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 14, 2021
Performance of a clinical risk prediction model for inhibitor formation in severe haemophilia AShermarke Hassan, Roberta Palla, Carla Valsecchi, et al.
Hemasphere|September 15, 2021
The EHA Research Roadmap: Blood Coagulation and Hemostatic DisordersSabine Eichinger, Pierre E Morange, Marco Cattaneo, et al.
Blood|April 25, 2012
Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpuraLuca A Lotta, Haifeng M Wu, Ian J Mackie, et al.
Pageof 5